Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up

[1]  David C. Jones,et al.  Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification , 2022, Acta Neuropathologica.

[2]  T. Merchant,et al.  Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children’s Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials , 2022, Acta Neuropathologica.

[3]  S. Pfister,et al.  DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population‐based study , 2022, Neuropathology and applied neurobiology.

[4]  M. Torre,et al.  The epidemiology of primary and metastatic brain tumors in infancy through childhood , 2022, Journal of Neuro-Oncology.

[5]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018. , 2021, Neuro-oncology.

[6]  M. Shago,et al.  Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study. , 2021, The Lancet. Child & adolescent health.

[7]  E. Ruppin,et al.  Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics. , 2021, Neuro-oncology.

[8]  M. Kool,et al.  Therapeutic implications of improved molecular diagnostics for rare CNS-embryonal tumor entities: results of an international, retrospective study. , 2021, Neuro-oncology.

[9]  M. Kool,et al.  Treatment of Embryonal Tumours with Multilayered Rosettes with Carboplatin/Etoposide Induction and High-dose Chemotherapy within the Prospective P-HIT Trial. , 2021, Neuro-oncology.

[10]  David T. W. Jones,et al.  DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study. , 2019, The Lancet. Child & adolescent health.

[11]  Naoki Kagawa,et al.  Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors , 2018, Acta Neuropathologica Communications.

[12]  David T. W. Jones,et al.  Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Martin Sill,et al.  Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience , 2018, Acta Neuropathologica.

[14]  Till Acker,et al.  DNA methylation-based classification of central nervous system tumours , 2018, Nature.

[15]  P. Due-Tønnessen,et al.  Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) – a retrospective analysis spanning 40 years of treatment , 2017, Acta oncologica.

[16]  J. Barnholtz-Sloan,et al.  Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010 , 2016, Neuro-oncology.

[17]  Roland Eils,et al.  New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs , 2016, Cell.

[18]  J. Gaudart,et al.  Embryonal tumors with multilayered rosettes in children: the SFCE experience , 2016, Child's Nervous System.

[19]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[20]  T. Jacques,et al.  Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour types , 2013, Acta Neuropathologica.

[21]  Hideo Nakamura,et al.  Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. , 2012, The Lancet. Oncology.

[22]  Richard G Grundy,et al.  Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts , 2011, Journal of Negative Results in BioMedicine.

[23]  M. J. van den Bent.  Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective , 2010, Acta neuropathologica.

[24]  G. Gustafsson,et al.  Classification, incidence and survival analyses of children with CNS tumours diagnosed in Sweden 1984–2005 , 2009, Acta paediatrica.

[25]  Roger E. Taylor,et al.  Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study. , 2006, European journal of cancer.

[26]  H. Bloom,et al.  Primitive neuroectodermal tumours of the cerebrum , 1985, Journal of Neuro-Oncology.

[27]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[28]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.

[29]  E. Housepian,et al.  An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. , 1969, Radiology.